Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin for Abstinence Initiation in Alcohol Dependence
NCT01141049Phase 3Completed
- Sponsor
- New York State Psychiatric Institute
- Start
- Aug 2010
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in alcohol dependence comparing Gabapentin with Placebo (2 arms). Primary endpoint: Percent of Heavy Drinking Days Per Week at 8 weeks. Started Aug 2010; status: completed.
02
Drugs
gabapentin
03
Conditions
alcohol dependence
Beyond the preview
Go deeper on NCT01141049.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01141049.